SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 20.20
+0.40 (2.02%)
May 9, 2025, 4:35 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 47.06 million as of May 9, 2025. Its market cap has increased by 163.89% in one year.
Market Cap
47.06M
Enterprise Value
46.85M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.20
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 47.06M, an increase of 199.20%. That is a compound annual growth rate of 14.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.88B |
| GSK plc | 56.05B |
| Haleon | 36.35B |
| Smith & Nephew | 9.26B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.32B |